On October 6, Option Care Health Inc rose 32.95% in regular trading, trading at $31.07/share, with Turnover of $11.92 billion.
The surge followed confirmation that McKesson and private equity firm Clayton Dubilier & Rice entered into a definitive agreement to acquire the company for $32.05 per share, reflecting a total enterprise value of about $5.8 billion. Under terms, CD&R will hold a 51% controlling stake and McKesson 49%. Option Care Health is the largest independent provider of home and alternate site infusion services in the United States, with nearly 40 years of clinical experience and a multidisciplinary team of approximately 2,900 clinicians serving patients with complex and chronic conditions across the country.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)